Bulletin
Investor Alert

New York Markets Open in:

Market Pulse Archives

Jan. 5, 2022, 6:57 a.m. EST

Pfizer, BioNTech to collaborate in developing mRNA-based shingles vaccine

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Pfizer Inc. (PFE)
  • X
    BioNTech SE ADR (BNTX)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Shares of Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.50% rose 1.6% in premarket trading Wednesday and BioNTech SE /zigman2/quotes/214419716/composite BNTX -4.81% gained 0.9%, after the drug makers said they will collaborate in developing a potential first mRNA-based shingles vaccine. The companies said they will leverage the antigen technology identified by Pfizer and BioNTech's mRNA platform technology, which were used to develop their COVID-19 vaccine. Clinical trials of the potential shingles vaccine are expected to start in the second half of 2022. Under terms of the collaboration agreement, Pfizer will make upfront payments of $225 million to BioNTech, including a $75 million cash payment and $150 million equity investment, while BioNTech will pay Pfizer $25 million for its antigen technology. BioNTech will be eligible to receive regulatory and sales milestone payments of up to $200 million. Pfizer's stock has rallied 46.6% over the past 12 months and BioNTech shares have soared 158.2%, while the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.39% has advanced 28.6%.

/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 50.67
+0.75 +1.50%
Volume: 19.44M
May 16, 2022 4:03p
P/E Ratio
11.63
Dividend Yield
3.16%
Market Cap
$281.94 billion
Rev. per Employee
$1.17M
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 151.20
-7.64 -4.81%
Volume: 1.27M
May 16, 2022 4:00p
P/E Ratio
3.17
Dividend Yield
1.01%
Market Cap
$38.60 billion
Rev. per Employee
$7.28M
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,008.01
-15.88 -0.39%
Volume: 2.21B
May 16, 2022 5:14p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.